This double-blind , randomized , parallel-group , placebo-controlled study investigated the efficacy and tolerability of fluticasone propionate aerosol ( 25 , 50 , or 100 mg bid for 12 weeks ) administered as primary maintenance therapy to patients whose mild to moderate asthma was inadequately controlled by as-needed use of an inhaled beta-agonist .
